Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Anti-Tau antibodies and methods of use 2022-7-25 2022-9-15
Compounds for imaging tau protein aggregates 2022-7-24 2022-9-01
Novel molecules for diagnosis 2022-3-09 2022-5-01
HUMANIZED ANTIBODIES AGAINST AMYLOID β 2022-1-11 2022-5-13
Antibody delivery 2021-12-17 2022-9-15
Anti-tdp-43 binding molecules and uses thereof 2021-11-22 2022-1-01
Anti-abeta vaccine therapy 2021-11-21 2022-1-01
Heterologous administration of tau vaccines 2021-10-22 2022-9-28
Antibodies binding to alpha-synuclein for therapy and diagnosis 2021-10-15 2022-4-21
Novel compounds 2021-10-11 2022-4-21
Bicyclic compounds for diagnosis and therapy 2021-8-25 2022-1-06
Compositions of Phosphorylated Tau Peptides and Uses Thereof 2021-8-19 2021-12-16
Humanized anti-tdp-43 binding molecules and uses thereof 2021-8-13 2022-2-17
Immunogenic compounds 2021-8-04 2022-2-10
Humanized antibody 2021-8-04 2022-7-21
Method of safe administration of phosphorylated tau peptide vaccine 2021-7-27 2021-9-30
D i h yd rooxazo le and thiourea derivatives modulating the nlrp3 inflammasome … 2021-6-18 2021-12-23
1, 3, 4, 5-Tetrahydro-2H-Pyrido[4,3-B]Indole Derivatives For The Treatment, … 2021-5-24 2021-6-24
Novel compounds for diagnosis 2021-5-07 2021-11-11
Novel compounds for diagnosis 2021-5-07 2021-11-11
Dose treatments of tauopathies 2021-3-18 2021-9-23
Novel compounds for diagnosis 2020-12-06 2021-1-31
Novel molecules for therapy and diagnosis 2020-12-04 2022-10-12
Tetrahydrobenzofuro[2,3-c]pyridine and beta-carboline compounds for the … 2020-11-30 2021-1-31
Humanized antibody 2020-11-16 2021-10-14
Therapeutic anti-abeta vaccines 2020-11-10 2021-1-29
Anti-tau antibodies and methods of use 2020-10-09 2022-6-07 2022-6-07
Micro-radiobinding assays for ligand screening 2020-9-30 2022-8-10
HUMANIZED ANTIBODIES AGAINST AMYLOID β 2020-7-22 2021-1-21
New method to prepare compound for imaging 2020-7-16 2020-10-30
Diagnostic compositions for pet imaging, a method for manufacturing the … 2020-7-12 2020-8-31
Misfolded tdp-43 binding molecules 2020-7-05 2020-8-31
Fused 1, 2-thiazoles and 1, 2-thiazines as NLRP3 modulators 2020-6-22 2022-2-01
Anti-Tau antibodies and methods of use 2020-6-05 2022-8-30 2022-8-30
Disaccharide synthetic lipid compounds and uses thereof 2020-5-26 2020-9-17
ANTI-TDP-43 BINDING MOLECULES AND USES THEREOF 2020-5-22 2021-11-17
MOLECULES FOR THERAPY AND DIAGNOSIS 2020-4-24 2021-11-03
Novel molecules for therapy and diagnosis 2020-4-20 2021-2-01
Humanized antibody 2020-4-08 2009-3-27
Novel compounds for the treatment, alleviation or prevention of disorders … 2020-2-20 2021-1-01
METHOD OF SAFE ADMINISTRATION OF PHOSPHORYLATED TAU PEPTIDE VACCINE 2020-2-07 2021-10-05
Novel compounds for the treatment, alleviation or prevention of disorders … 2020-1-09 2020-5-14
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of … 2019-12-11 2020-8-13
Novel Compounds for the Treatment, Alleviation or Prevention of Disorders … 2019-5-20 2021-7-15
THERAPEUTIC ANTI-Ab VACCINES 2019-4-09 2020-10-14
Anti-abeta therapeutic vaccine 2019-4-09 2021-1-01
COMPOUNDS FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH … 2019-3-08 2021-8-18
Gamma-carboline compounds for the detection of tau aggregates 2019-1-22 2021-2-18
Azacarboline compounds for the detection of tau aggregates 2019-1-22 2021-2-11
HUMANIZED ANTIBODY 2018-8-21 2020-1-15
Humanized antibody against amyloid beta 2018-7-03 2018-7-19
Humanized antibody igg1 2018-2-22 2019-1-31
HUMANIZED ANTIBODIES AGAINST AMYLOID β 2017-12-20 2018-6-21
Compounds for imaging tau protein aggregates 2017-7-21 2019-8-29
Pharmaceutical composition 2017-5-23 2017-12-22
Aβ1-42 SPECIFIC MONOCLONAL ANTIBODIES HAVING THERAPEUTIC PROPERTIES 2017-3-31 2017-9-07
Bicyclic compounds for diagnosis and therapy 2017-3-10 2022-3-25
Pharmaceutical composition 2017-1-20 2017-6-29
MONOCLONAL ANTIBODY AFTER INCUBATION WITH MONOMERIC PEPTIDES Ab 1-42 INHIBITES … 2017-1-12 2018-4-18
For the method for vaccination for the autoantigen in people patient 2016-11-02 2018-8-31
Methods of diagnosing diseases caused by or associated with neurofibrillary … 2016-10-28 2018-9-04 2018-9-04
SAFE AND FUNCTIONAL HUMANIZED ANTI β-AMYLOID ANTIBODY 2016-9-12 2017-3-16
Novel imaging compounds 2016-7-15 2018-9-20
Disaccharide synthetic lipid compounds and uses thereof 2016-6-07 2017-12-07
Anti-tau antibodies and methods of use tau 2016-5-30 2017-2-03
Phosphospecific antibodies recognising tau 2016-4-13 2016-6-16
Humanized Antibody 2015-12-22 2016-8-25
Compounds for the treatment of diseases associated with amyloid or amyloid-like … 2015-11-02 2019-12-10 2019-12-10
Humanized tau antibody tau 2015-10-06 2016-3-24
Polynucleotides encoding anti-amyloid beta monoclonal antibodies 2015-9-22 2017-3-07 2017-3-07
Dihydropyridopyrrole derivatives as tau-pet-ligands 2015-7-15 2017-1-18
Method for therapeutic use 2015-7-06 2015-12-10
Methods and compositions comprising supramolecular constructs 2015-6-08 2015-7-03
A beta 1-42 specific monoclonal antibodies with therapeutic properties 2015-4-08 2015-4-30
Use of anti-amyloid beta antibody in ocular diseases 2015-2-19 2016-12-15 2016-12-15
Use of anti-amyloid beta antibody in ocular diseases 2015-2-06 2016-10-27 2016-10-27
Carbazole and carboline compounds for use in the diagnosis, treatment, … 2015-1-21 2020-5-26 2020-5-26
Methods and compositions comprising supramolecular constructs 2014-11-26 2015-7-02
2,6-diaminopyridine compounds suitable for treating diseases associated with … 2014-9-30 2017-7-11 2017-7-11
Vaccine therapy 2014-3-20 2017-8-30
Use of anti-amyloid beta antibody in ocular diseases 2014-2-26 2014-4-11
MONOCLONAL ANTI-β AMYLOID ANTIBODY 2013-12-10 2014-5-15
Disaccharide Synthetic Lipid Compounds and Uses Thereof 2013-4-12 2015-4-23
Phosphospecific antibodies recognising tau 2013-4-11 2016-5-19 2016-5-19
Humanized antibody against amyloid beta 2013-4-07 2019-1-03 2019-1-03
Memory genes 2013-3-15 2013-9-26
Therapeutic vaccine 2013-2-13 2013-6-27
Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting … 2013-2-01 2013-6-20
A beta 1-42 specific monoclonal antibodies with therapeutic properties 2012-10-19 2015-4-30 2015-4-30
Pharmaceutical composition 2012-10-05 2013-6-01
Método de administração segura de vacina de peptídeo de tau fosforilada 2020-2-07 2021-10-05